BNP Paribas Financial Markets
VAXX

BNP Paribas Financial Markets’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

BNP Paribas Financial Markets’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-92
Closed -$182 – 4775
2022
Q3 		$182 Buy
+92
New +$192 ﹤0.01% 4617

Other funds holding VAXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
SM
Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BNP Paribas Financial Markets's VAXX Position: Q4 2022 in Review

BNP Paribas Financial Markets sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q4 2022, closing a stake of 92 shares — an estimated $182 sold.

BNP Paribas Financial Markets first reported a position in VAXX in Q3 2022 and held it in 1 quarter. The position peaked at $182 in Q3 2022. 30 funds tracked by Wall St. Rank hold VAXX as of Q4 2022.

  • BNP Paribas Financial Markets reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 92 Vaxxinity, Inc. Class A Common Stock shares in Q4 2022, an estimated $182.
  • BNP Paribas Financial Markets first reported a position in Vaxxinity, Inc. Class A Common Stock in Q3 2022 and held it in 1 quarter.
  • BNP Paribas Financial Markets's Vaxxinity, Inc. Class A Common Stock position peaked at $182 in Q3 2022.
  • 30 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q4 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.